Bisphosphonate therapy for severe osteogenesis imperfecta

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue SUPPL. 2, 2000, Pages 989-992

  Glorieux, F H ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

Bisphosphonates; Osteogenesis imperfecta; Pamidronate

Indexed keywords

ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE MINERAL; CALCITONIN; COLLAGEN TYPE 1; FLUORIDE; MAGNESIUM OXIDE; PAMIDRONIC ACID;

BONE DENSITY; CHILD; CHRONIC PAIN; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE SEVERITY; FATIGUE; FRACTURE; FRACTURE HEALING; GROWTH PLATE; GROWTH RATE; HUMAN; LIMB MALFORMATION; OSTEOGENESIS IMPERFECTA; QUALITY OF LIFE; SIDE EFFECT; SPINE MALFORMATION; TREATMENT OUTCOME; WALKING AID;

CHILD, PRESCHOOL; DIPHOSPHONATES; HUMAN; INFANT; MALE; OSTEOGENESIS IMPERFECTA;

EID: 0033784788     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Genetic heterogeneity in osteogenesis imperfecta
2. Type V osteogenesis imperfecta - A new form of brittle bone disease
3. Genomic localisation of a new variant of osteogenesis imperfecta to chromosome 3p22-24.1
4. New approaches to treatment of osteogenesis imperfecta
5. Cyclical pamidronate therapy in children with severe osteogenesis imperfecta
6. Bisphosphonates: Mechanism of action
7. Pamidronate treatment of severe osteogenesis imperfecta in children under three years of age